Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes

European Journal of Medicinal Chemistry

Volumn 45, Issue 6, 2010, Pages 2634-2637

  Zhang, Jinchao ^a   Li, Luwei ^a   Ji, Xiaoyu ^a   Sun, Jing ^a   Wang, Liwei ^a   Zhang, Ying ^b  

^a HEBEI UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Binuclear platinum(II) complexes; Characterization; Cytotoxicity; Synthesis

Indexed keywords

3 METHYLANILINE; 4 METHYLANILINE; AMINE; ANILINE; ANILINE DERIVATIVE; ANTINEOPLASTIC AGENT; BUTYLAMINE; CISPLATIN; DIETHYLAMINE; ISOPROPYLAMINE; METHYLANILINE; PLATINUM COMPLEX; PROPYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CONDUCTANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; INFRARED SPECTROMETRY; MASS SPECTROMETRY; NITROBLUE TETRAZOLIUM TEST; PROTON NUCLEAR MAGNETIC RESONANCE; THERMAL ANALYSIS; THERMOSTABILITY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG STABILITY; HUMANS; INHIBITORY CONCENTRATION 50; IODINE; ORGANOPLATINUM COMPOUNDS; SPECTRUM ANALYSIS; TEMPERATURE;

EID: 77950953934     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.01.055     Document Type: Article

References (23)

1. Boulikas T., and Vougiouka M. Oncol. Rep. 10 (2003) 1663-1682
2. Ho Y.P., Au-Yeung S.C.F., and To K.K.W. Med. Res. Rev. 23 (2003) 633-655
3. Kostova I. Recent Pat. Anti-Cancer Drug Discovery 1 (2006) 1-22
4. Jakupec M.A., Galanski M., and Keppler B.K. Rev. Physiol. Biochem. Pharmacol. 146 (2003) 1-53
5. Wong E., and Giandomenico C.M. Chem. Rev. 99 (1999) 2451-2466
6. Farrell N.P., de Almeida S.G., and Skov K.A. J. Am. Chem. Soc. 110 (1988) 5018-5019
7. Broomhead J.A., Rendina L.M., and Sterns M. Inorg. Chem. 31 (1992) 1880-1889
8. Broomhead J.A., Rendina L.M., and Webster L.K. J. Inorg. Biochem. 49 (1993) 221-234
9. Qu Y., Appleton T.G., Hoeschele J.D., and Farrell N.P. Inorg. Chem. 32 (1993) 2591-2593
10. Rauter H., Domenico R.D., Menta E., Oliva A., Qu Y., and Farrell N. Inorg. Chem. 36 (1997) 3919-3927
11. Qu Y., Rauter H., Soares Fontes A.P., Bandarage R., Kelland L.R., and Farrell N. J. Med. Chem. 43 (2000) 3189-3192
12. Hegmans A., Qu Y., Kelland L.R., Roberts J.D., and Farrell N. Inorg. Chem. 40 (2001) 6108-6114
13. Qu Y., Fitzgerald J.A., Rauter H., and Farrell N. Inorg. Chem. 40 (2001) 6324-6327
14. Jansen B.A.J., van der Zwan J., den Dulk H., Brouwer J., and Reedijk J. J. Med. Chem. 44 (2001) 245-249
15. Zhang J.C., Liu L., Gong Y.Q., Zheng X.M., Yang M.S., Cui J.R., and Shen S.G. Eur. J. Med. Chem. 44 (2009) 2322-2327
16. Geary W.J. Coord. Chem. Rev. 7 (1971) 81-122
17. Adams D.M., and Chandler P.J. Chem. Commun. 3 (1966) 69-70
18. Rochon F.D., and Kong P.C. Can. J. Chem. 64 (1986) 1894-1896
19. Rochon F.D., and Buculei V. Inorg. Chim. Acta 358 (2005) 3919-3926
20. Najajreh Y., Khazanov E., Jawbry S., Ardeli-Tzaraf Y., Perez J.M., Kasparkova J., Brabec V., Barenholz Y., and Gibson D. J. Med. Chem. 49 (2006) 4665-4673
21. Kelland L.R., Murrer B.A., Abel G., Giandomenico C.M., and Mistry P. Cancer Res. 52 (1992) 822-828
22. Khokhar A.R., Deng Y.J., Al-Baker S., Yoshida M., and Siddik Z.H. J. Inorg. Biochem. 51 (1993) 677-687
23. Mosmann T.R. J. Immunol. Methods 65 (1983) 55-63